Clinical Trials on 尿素循环障碍 in Australia
总计4272个结果
-
The AlfredAstraZeneca; Hospira, now a wholly owned subsidiary of Pfizer; Janssen-Cilag Ltd.招聘中
-
Spark Therapeutics完全的血液病 | 甲型血友病 | 遗传性凝血障碍 | 凝血蛋白紊乱 | 出血性疾病 | 先天性遗传病 | 遗传病,X连锁 | 血液凝固障碍 | 因子 VIII 缺乏症美国, 澳大利亚, 泰国, 加拿大
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital Melbourne未知
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation未知
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.未知
-
The University of New South WalesAustralian Government Department of Health and Ageing完全的
-
Anavex Life Sciences Corp.完全的
-
University of WaterlooMcGill University; Retina Foundation of the Southwest; Queensland University of Technology完全的
-
The University of Western AustraliaKing Edward Memorial Hospital完全的
-
Bayside Health完全的
-
University of ManitobaUniversity of South Australia完全的
-
Medtronic Cardiac Rhythm and Heart Failure完全的
-
Sir Charles Gairdner Hospital完全的
-
Medical University InnsbruckParacelsus Medical University; Austrian Science Fund (FWF)完全的
-
Sanofi完全的
-
The University of Western AustraliaJohns Hopkins University; Vanderbilt University Medical Center; Guy's and St Thomas' NHS Foundation... 和其他合作者招聘中
-
Australasian Leukaemia and Lymphoma GroupMerck Sharp & Dohme LLC; Novartis Pharmaceuticals未知
-
University of TasmaniaNational Health and Medical Research Council, Australia; University of Leeds; University of Sydney招聘中
-
Medical University of Vienna完全的
-
Peter MacCallum Cancer Centre, AustraliaJanssen, LP招聘中
-
GlaxoSmithKline完全的
-
Genentech, Inc.招聘中
-
University of AdelaideSalk Institute for Biological Studies; University of South Australia完全的
-
Novo Nordisk A/S完全的
-
The University of QueenslandNational Health and Medical Research Council, Australia完全的
-
Asceneuron Pty Ltd.Neuroscience Trials Australia; Asceneuron S.A.终止